PBPIA
INZY

Pivotal bioVenture Partners Investment Advisor’s Inozyme Pharma INZY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$18M Hold
4,494,851
11.14% 4
2025
Q1
$4.09M Hold
4,494,851
3.31% 5
2024
Q4
$12.5M Hold
4,494,851
8.41% 4
2024
Q3
$23.5M Hold
4,494,851
13.95% 2
2024
Q2
$20M Hold
4,494,851
15.41% 2
2024
Q1
$34.4M Hold
4,494,851
22.13% 2
2023
Q4
$19.1M Hold
4,494,851
4.86% 4
2023
Q3
$18.9M Buy
4,494,851
+833,333
+23% +$3.5M 7.53% 4
2023
Q2
$20.4M Buy
3,661,518
+447,932
+14% +$2.49M 6.72% 4
2023
Q1
$18.4M Buy
3,213,586
+552,432
+21% +$3.17M 7.58% 3
2022
Q4
$2.79M Hold
2,661,154
1.22% 8
2022
Q3
$7.13M Hold
2,661,154
2.61% 6
2022
Q2
$12.7M Buy
2,661,154
+1,070,000
+67% +$5.1M 6.39% 4
2022
Q1
$6.51M Hold
1,591,154
3.08% 8
2021
Q4
$10.9M Hold
1,591,154
4.54% 7
2021
Q3
$18.4M Hold
1,591,154
6.52% 6
2021
Q2
$27.1M Hold
1,591,154
10.69% 4
2021
Q1
$31.5M Hold
1,591,154
10.11% 3
2020
Q4
$32.8M Buy
+1,591,154
New +$32.8M 10.83% 4